Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Combined burden and functional impact tests for cancer driver discovery using DriverPower

  • PCAWG Drivers and Functional Interpretation Working Group
  • , PCAWG Consortium
  • Ontario Institute for Cancer Research
  • University of Toronto
  • Wellcome Trust Genome Campus
  • Baylor College of Medicine
  • Jackson Laboratory
  • University of Texas MD Anderson Cancer Center
  • Broad Institute
  • Dana-Farber Cancer Institute
  • Harvard University
  • Aarhus University
  • RIKEN
  • Technical University of Denmark
  • University of Copenhagen
  • Cambridge University Hospitals NHS Foundation Trust
  • University of Cambridge
  • University of Bern
  • Icahn School of Medicine at Mount Sinai
  • German Cancer Research Center
  • Heidelberg University 
  • Korea Advanced Institute of Science and Technology
  • Institute for Research in Biomedicine
  • Pompeu Fabra University
  • Cornell University
  • Uppsala University
  • Barcelona Supercomputing Center (BSC)
  • University of Queensland
  • European Molecular Biology Laboratory
  • University of Porto
  • University of Milan - Bicocca
  • University of Melbourne
  • Yale University
  • Massachusetts General Hospital
  • Barcelona Institute of Science and Technology (BIST)
  • University of California Santa Cruz
  • Stanford University
  • University of Texas Health Science Center at Houston
  • Simon Fraser University
  • Memorial Sloan-Kettering Cancer Center
  • Swiss Federal Institute of Technology Zurich
  • Swiss Institute of Bioinformatics
  • University of Zurich

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

44 Atsauces (Scopus)

Kopsavilkums

The discovery of driver mutations is one of the key motivations for cancer genome sequencing. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumour types, we describe DriverPower, a software package that uses mutational burden and functional impact evidence to identify driver mutations in coding and non-coding sites within cancer whole genomes. Using a total of 1373 genomic features derived from public sources, DriverPower’s background mutation model explains up to 93% of the regional variance in the mutation rate across multiple tumour types. By incorporating functional impact scores, we are able to further increase the accuracy of driver discovery. Testing across a collection of 2583 cancer genomes from the PCAWG project, DriverPower identifies 217 coding and 95 non-coding driver candidates. Comparing to six published methods used by the PCAWG Drivers and Functional Interpretation Working Group, DriverPower has the highest F1 score for both coding and non-coding driver discovery. This demonstrates that DriverPower is an effective framework for computational driver discovery.

OriģinālvalodaAngļu
Raksta numurs734
Lapas (no-līdz)1-12
ŽurnālsNature Communications
Sējums11
Izdevuma numurs1
DOIs
Publikācijas statussPublicēts - 1 dec. 2020

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

OECD Zinātnes nozare

  • 3. Medicīnas un veselības zinātnes

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Combined burden and functional impact tests for cancer driver discovery using DriverPower”. Kopā tie veido unikālu nospiedumu.

Citēt šo